Hematology
| Acute myeloid leukemia
Hematology
Acute myeloid leukemia
How I treat refractory and relapsed acute myeloid leukemia
book_2
Source:
Blood. 2024;143(1):11-20
calendar_today
Published on Medfyle:
May 2024
import_contacts
4
min
In this medfyle
In the field of acute myeloid leukemia (AML), there have been important advances in recent years, such as greater knowledge of the mutational landscape and its change throughout its evolution, the refinement of techniques for monitoring residual or progressive disease. , and the incorporation of targeted therapy into routine clinical practice. However, relapses are frequent; up to 70% of patients with adverse genetic alterations have a very poor prognosis. This work summarizes in a clear and very dynamic way the strategies currently available for addressing AML in R/R.
